HSDT | tickerfilter.com

Fundamental analysis

29%

Profitability 33%

Dept financing 19%

Liquidity 38%

Performance 25%

Company vs Stock growth

+ Add row to compare

Performance

5 Days

4.66%

1 Month

5.38%

3 Months

-47.67%

6 Months

-82.71%

1 Year

-90.37%

2 Year

-97.27%

Key data

Stock price

$0.76

P/E Ratio

-0.31

DAY RANGE

N/A - N/A

EPS

-$7.62

52 WEEK RANGE

$0.65 - $13.43

52 WEEK CHANGE

-$0.90

MARKET CAP

2.732 M

YIELD

N/A

SHARES OUTSTANDING

3.576 M

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

11/11/2024

BETA

0.20

PUBLIC FLOAT

AVERAGE 10 VOLUME

$59,936

AVERAGE 30 VOLUME

$52,205

Company detail

CEO: Philippe Deschamps
Region: US
Website: http://www.heliusmedical.com/
Employees: 34
IPO year: -

Issue type: Common Stock
Market: XNAS
Industry: Surgical and Medical Instrument Manufacturing
Sector: Manufacturing

helius medical technologies, inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. the company's product is portable neuromodulation stimulator (pons), a medical device in canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. its pons device treats neurostimulation of cranial nerves via the tongue to restore lost function. the company is headquartered in newtown, pennsylvania.

HSDT - Helius Medical Technologies Inc - Ordinary Shares - Class A